Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Plastic and Reconstructive Surgery|December 3, 2009
Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protectiveJustin B Maxhimer, Hubert B Shih, Jeffrey S Isenberg, et al.
Kidney International|June 5, 2016
CD47 regulates renal tubular epithelial cell self-renewal and proliferation following renal ischemia reperfusionNatasha M Rogers, Zheng J Zhang, Jiao-Jing Wang, et al.
Frontiers in Physiology|June 15, 2018
Computer Simulation of TSP1 Inhibition of VEGF-Akt-eNOS: An Angiogenesis Triple ThreatHojjat Bazzazi, Yu Zhang, Mohammad Jafarnejad, et al.
Cell Transplantation|November 10, 2021
Towards a Rational Balanced Pancreatic and Islet Allocation SchemaFouad Kandeel, Mohamed El-Shahawy, Gagandeep Singh, et al.
Cancer Biology & Therapy|July 22, 2010
Nimotuzumab with chemoradiation confers a survival advantage in treatment-naïve head and neck tumors over expressing EGFRChetana Basavaraj, Patricia Sierra, Jatteppanavar Shivu, et al.
Expert Review of Neurotherapeutics|May 7, 2008
Boosting controlled autoimmunity: a new therapeutic target for CNS disordersDiana García del Barco, Jorge Berlanga, Eduardo Penton, et al.
American Journal of Physiology. Renal Physiology|August 10, 2012
Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its managementNatasha M Rogers, Mingyi Yao, Enrico M Novelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2005
Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1Lisa A Ridnour, Jeffrey S Isenberg, Michael G Espey, et al.
Expert Opinion on Therapeutic Targets|October 30, 2012
Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47David R Soto-Pantoja, Erica V Stein, Natasha M Rogers, et al.
Pageof 12